We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Expressive Writing for Heart Healing (WrittenHeart)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01253486
First Posted: December 3, 2010
Last Update Posted: September 25, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Gianluca Castelnuovo, Istituto Auxologico Italiano
  Purpose
This study will determine whether the psychological and physical benefits of expressive writing extend to obese in-patients with Ischemic Heart Disease (IHD)referred to cardiac rehabilitation

Condition Intervention
Ischemic Heart Disease Obesity Behavioral: Disease-related Expressive writing Behavioral: Active Comparator: Traditional expressive writing Behavioral: Sham Comparator: Neutral writing

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Use of Expressive Writing in the Cardiac Rehabilitation of Obese In-patients With Ischemic Heart Disease (IHD)

Resource links provided by NLM:


Further study details as provided by Gianluca Castelnuovo, Istituto Auxologico Italiano:

Primary Outcome Measures:
  • SF12 [ Time Frame: 1 year ]
    The SF12 is a generic measure of both physical and emotional components of health-related quality of life

  • BDI-II [ Time Frame: 1 year ]
    The Beck Depression Inventory is a measure of depressive symptoms

  • BDI [ Time Frame: 1 year ]
    The Beck Anxiety Inventory is a measure of cognitive and somatic symptoms of anxiety

  • Brief-PTGI [ Time Frame: 1 year ]
    The Brief Post-Traumatic Growth Inventory is a measure of positive growth following adversity


Secondary Outcome Measures:
  • BMI [ Time Frame: 1 year ]
    Body Mass Index (BMI) is a measure of obesity and is calculated as weight in kilograms divided by height in meters squared

  • Multiple Coronary Risk Factors [ Time Frame: 1 year ]
    Hypertension, HDL, LDL,

  • METs [ Time Frame: 1 year ]
    Metabolic equivalents are a measure of exercise capacity. 1 MET represents the amount of oxygen consumed at rest and is equal to approximately 3.5 ml O2 kg-1 min-1


Enrollment: 100
Study Start Date: January 2010
Study Completion Date: May 2013
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Disease-related expressive writing
Participants in the disease-related expressive writing condition write about their feelings about cardiac disease four times, for at least 20 minutes each time, during a two week period
Behavioral: Disease-related Expressive writing
Participants in the disease-related expressive writing condition write about their feelings about cardiac disease four times, for at least 20 minutes each time, during a two week period.
Active Comparator: Traditional expressive writing
Participants in the traditional expressive writing condition write about their feelings about one or more stressful experiences they lived in the past, for at least 20 minutes each time, during a two week period
Behavioral: Active Comparator: Traditional expressive writing
Participants in the traditional expressive writing condition write about their feelings about one or more stressful experiences they lived in the past, for at least 20 minutes each time, during a two week period
Sham Comparator: Neutral writing
Participants in the neutral writing condition write about the facts about cardiac disease, for at least 20 minutes each time, during a two week period
Behavioral: Sham Comparator: Neutral writing
Participants in the neutral writing condition write about the facts about cardiac disease, for at least 20 minutes each time, during a two week period
No Intervention: Control condition
Participants in the control condition do not receive any intervention and complete only the assessments

Detailed Description:
Expressive writing, for as little as 3-5 sessions of 20 minutes, has been found to improve both physical and psychological health based on health outcome measures such as number of doctor's visits and hospital days, blood pressure control, lung and immune function, pain, anxiety and depression. Given its simplicity and obvious advantages in terms of cost-effectiveness, expressive writing has great potential as a therapeutic tool or as a means of self-help, either alone or as an adjunct to traditional therapies. This modality has not been studied in obese patients with Ischemic Heart Disease.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 70 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • obesity
  • Ischemic Heart disease
  • Signed informed consent

Exclusion Criteria:

  • Visual or manual limitations that preclude reading and writing
  • Unwilling to participate
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01253486


Locations
Italy
San Giuseppe Hospital, Istituto Auxologico Italiano IRCSS
Verbania, Italy, 28921
Sponsors and Collaborators
Istituto Auxologico Italiano
Investigators
Principal Investigator: Gianluca Castelnuovo, Ph.D. Istituto Auxologico Italiano
  More Information

Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Gianluca Castelnuovo, Professor, Istituto Auxologico Italiano
ClinicalTrials.gov Identifier: NCT01253486     History of Changes
Other Study ID Numbers: GMM 2010
First Submitted: December 2, 2010
First Posted: December 3, 2010
Last Update Posted: September 25, 2013
Last Verified: September 2013

Keywords provided by Gianluca Castelnuovo, Istituto Auxologico Italiano:
expressive writing
cardiac rehabilitation

Additional relevant MeSH terms:
Ischemia
Heart Diseases
Myocardial Ischemia
Coronary Artery Disease
Pathologic Processes
Cardiovascular Diseases
Vascular Diseases
Coronary Disease
Arteriosclerosis
Arterial Occlusive Diseases